NUCB2/Nesfatin-1 drives breast cancer metastasis through the up-regulation of cholesterol synthesis via the mTORC1 pathway

Overview of attention for article published in Journal of Translational Medicine, June 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 4 publications that cite this research output.

4

The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.

NUCB2 inhibition antagonizes osteosarcoma progression and promotes anti-tumor immunity through inactivating NUCKS1/CXCL8 axis

Article in Cancer Letters (April 2024)

A combined immune and exosome-related risk signature as prognostic biomakers in acute myeloid leukemia

Article in Hematology (January 2024)

The role of LSM1 in breast cancer: Shaping metabolism and tumor-associated macrophage infiltration

Article in Pharmacological Research (November 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.